RZLT
Rezolute Inc

910
Mkt Cap
$834.71M
Volume
0.00
52W High
$10.04
52W Low
$2.22
PE Ratio
-9.44
RZLT Fundamentals
50D MA
$8.13
Beta
0.90
Avg. Volume
1.4M
EPS (Annual)
-$0.9791
P/B
4.93
Rev/Employee
$0.00
Loading...
Loading...
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
71

Frequently Asked Questions

What is Market Cap of Rezolute Inc?
What is the 52-week high for Rezolute Inc?
What is the 52-week low for Rezolute Inc?
What is the PE ratio of Rezolute Inc?
What is the Price-to-Book ratio of Rezolute Inc?
What is the 50-day moving average of Rezolute Inc?
How many employess does Rezolute Inc has?

Latest RZLT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.